Are you involved in the cell and gene therapy development? Would you like to showcase your technologies and products to potential partners and clients from Japan and beyond? This July, take advantage of an exclusive opportunity to present your innovations and expand your network during the Japan Session in Tokyo. Don’t miss this exceptional chance to connect with your target audience and grow your business.
The Japan Session will be held alongside the 31st Annual Meeting of the Japan Society of Gene and Cell Therapy (JSGCT 2025), taking place in Tokyo from July 23 to July 25, 2025. This year's event will spotlight the latest advancements in the field, with a focus on innovations in cell and gene therapy, manufacturing best practices, process development, scale-out strategies, and exclusive case studies. Discussions will also cover technical and clinical achievements in areas such as cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies.
Join us to network with top Japanese professionals, discover market access strategies, forge partnerships in the Japanese market, and explore cutting-edge developments. We are excited to welcome you to the Japan Session 2025!
Please note: this session is being planned as an in-person event that requires travel to Japan. There is no virtual or hybrid option for attendees.
Japan's industries, academic institutions, and other organizations are involved in the cell and gene therapy sector. Relevant sectors include, but are not limited to:
Exhibit booths start at W180×D90×H210cm.
Presenters are provided a 30-minute timeslot to give product or technology presentations.
"Roadmap for Japan" - Gain valuable insights and knowledge about the Japanese market by taking part in the seminar "Access roadmap for Japan - Rroutes to adoption for cell and gene therapies in Japan".
* The seminar topic is subject to change.
The application deadline is 30 April, 2025.